# Lundbeckfonden Ventures: portfolio, investments and team > Lundbeckfonden Ventures is a vc firm based in Denmark. 7 investments on record, latest May 2019. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/lundbeckfonden-ventures (Millionrounds; every figure on the page links to its filing or article) Denmark · [Investor](https://millionrounds.com/investors) # Lundbeckfonden Ventures Last cheque observed May 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet VC firm Seed Series A Series B Analytics Human Resources Biotechnology Cheques on record **0%** of best year **0** **cheques in 12 months**, 7 on record Since the last cheque **2716** days **00** hrs **00** min **00** sec Median round **$31M** Rounds led **0 of 7** Sole investor **1 rounds** Mostly in **United States, 57%** Pitch Lundbeckfonden Ventures ## Lundbeckfonden Ventures highlights - 01 7 rounds on record - 02 Mostly Series A and Series C: 80% of its rounds - 03 Sole investor in 1 rounds, median $23M ## What they do - **Type:** VC firm (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B Growth Pre-IPO - **Sectors:** Analytics Human Resources Biotechnology - **Based in:** Copenhagen, Denmark - **Cold pitches:** Not accepted ## The record Every round we can evidence, newest first **7 appearances** - **2019** 2 rounds - **May** **[Reneo Pharmaceuticals](https://millionrounds.com/company/reneo-pharmaceuticals)** Series A · US · FinSMEs **$50M** With 3 others - **Jan** **[Tiburio Therapeutics](https://millionrounds.com/company/tiburio-therapeutics)** Series A · US · FinSMEs **$31M** With 3 others - **2018** 1 round - **Aug** **[Dysis Medical](https://millionrounds.com/company/dysis-medical)** GB · FinSMEs **$23M** Sole investor - **2017** 4 rounds - **Dec** **[Aura Biosciences](https://millionrounds.com/company/aura-biosciences)** Series C · US · 4-traders **$30M** With 9 others - **Dec** **Atox Bio** IL · FinSMEs **$30M** With 6 others - **Mar** **[Spero Therapeutics](https://millionrounds.com/company/spero-therapeutics)** Series C · US · FinSMEs **$52M** With 8 others - **Jan** **[Enterome](https://millionrounds.com/company/enterome)** Series D · FR · FinSMEs **$39M** With 6 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **3** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## The cheque Seed Series A Series B Median round joined **$31M** the round, not its cheque Alone, median **$23M** Led 0 of 7 rounds **0%** - **Sole investor:** 1 rounds - **Last cheque:** May 2019 Rounds by stage said on their site - Series A said *2* - Series C *2* - Series D *1* - Seed said *-* - Series B said *-* - Growth said *-* - Pre-IPO said *-* Cheques by year Led Joined 2017 2019 Often in the room with - [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) 2 - [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 2 - [SR One](https://millionrounds.com/fund/sr-one) 2 **Pitching Lundbeckfonden Ventures?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Lundbeckfonden Ventures. A count of rooms they were both in, not a relationship either has claimed. [**Alexandria Real Estate Equities** VC firm **2** rounds together](https://millionrounds.com/fund/alexandria)[**New Enterprise Associates** VC firm **2** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**SR One** Corporate VC **2** rounds together](https://millionrounds.com/fund/sr-one) ## Recently backed The latest companies Lundbeckfonden Ventures put money into. [**Spero Therapeutics** $52M · Mar 2017](https://millionrounds.com/company/spero-therapeutics)[**Enterome** $39M · Jan 2017](https://millionrounds.com/company/enterome) ## Quick answers about Lundbeckfonden Ventures ### What does Lundbeckfonden Ventures invest in? Lundbeckfonden Ventures invests most often at Series A and Series C (80% of the rounds on record), in sectors such as Analytics, Human Resources and Biotechnology. ### How active is Lundbeckfonden Ventures? 7 investments on record, 0 of them in the last 12 months. The most recent was in May 2019. ### What has Lundbeckfonden Ventures invested in recently? Its most recent investments on record: Reneo Pharmaceuticals (Series A, May 2019), Tiburio Therapeutics (Series A, Jan 2019) and Dysis Medical (Undisclosed round, Aug 2018). ### How big are Lundbeckfonden Ventures's cheques? The median round it joins is $31M. ### Does Lundbeckfonden Ventures lead rounds? Rarely, if at all: none of its 7 investments on record names it as the lead. ### Where does Lundbeckfonden Ventures invest? Most of the companies it backs are in the United States (57%), the United Kingdom (14%) and Israel (14%). ### Is Lundbeckfonden Ventures investing now? No investments in the last 12 months; the latest was in May 2019. ### Who does Lundbeckfonden Ventures invest alongside? Most often Alexandria Real Estate Equities (2 rounds together), New Enterprise Associates (2 rounds together) and SR One (2 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=lundbeckfonden-ventures) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=lundbeckfonden-ventures)